Merit Medical Systems, Inc. (MMSI) PT Lowered to $106 at Piper Sandler

Piper Sandler analyst Jason Bednar lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $106.00 (from $113.00) while maintaining an Overweight rating.

The analyst commented: "It's earnings season, so it shouldn't come as a major surprise that we're comfortable anticipating positive updates from MMSI. Management already pre-announced revenue, but we're calling for GM% to surprise to the upside (again), and we can envision even conservative guidance from management leading to Street estimates nudging higher post-call (the CGI 3-year LRP that runs through 2026 provides a convenient floor). Plus, WRAPSODY seems largely de-risked at this point, and valuation is bumping along five-year lows."

You May Also Be Interested In

• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'
• Axos Financial (AX) PT Raised to $120 at Benchmark
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)